The Serum Institute of India has called the allegations made by a volunteer of SII’s vaccine candidate ‘malicious’.
On November 21, a 40-year-old Chennai based volunteer of the vaccine candidate Covishield, filed a legal suit case against SII. The volunteer claimed that there was no adverse reaction for the first 10 days after the vaccination, but on the 11th day, he developed symptoms of ‘Acute Encephalopathy’ that led to a decline in his ability to reason and concentrate, memory loss and personality change.
He had also sent a legal notice to ICMR, DCGI, AstraZeneca and Oxford University to stop testing, manufacturing and distributing vaccine. The legal notice claims the participant began experiencing headaches and then endured a seven-day stay in the intensive care unit (ICU).
On not receiving a reply, the volunteer has also filed a case. “While the Serum Institute of India is sympathetic with the volunteer’s medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer. The volunteer is falsely laying the blame for his medical problems on the Covid vaccine trial,” SII said in a statement.
Also Read : PAYTM MONEY GOES DEEPER INTO BROKING, OPENS IPO INVESTMENTS
